Newsroom | 3978 results

ORLANDO, Fla.--(BUSINESS WIRE)--Hesperos wins ACC.25 Pitch, showcasing how its Human-on-a-Chip® is accelerating drug development and reducing reliance on animal testing....

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene insertion, and gene excision programs, today announced that five abstracts detailing Precision’s wholly owned or partnered programs have been accepted for presentation at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 13-17,...

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on April 30, 2025. Three individuals were hired by Adicet in April 2025. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 206,800 shares of Adicet’s common stock with an exercise price of $0.66 per...

DUBLIN--(BUSINESS WIRE)--The "Stromal Vascular Fraction - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Stromal Vascular Fraction was valued at US$98.2 Million in 2024 and is projected to reach US$127.8 Million by 2030, growing at a CAGR of 4.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the mos...

SEATTLE & PITTSBURGH--(BUSINESS WIRE)--Curi Bio and Cook MyoSite Announce Strategic Scientific Collaboration to Advance Translational Human Muscle Disease Models...

SAN DIEGO--(BUSINESS WIRE)--Capstan Therapeutics today announced that the Company will present at upcoming scientific conferences and showcase new preclinical data on CPTX2309....

MADISON, Wis.--(BUSINESS WIRE)--FUJIFILM Cellular Dynamics, Inc., a leading developer and manufacturer of human induced pluripotent stem cells (iPSC), today announces the appointment of Delara Motlagh, as its new chief operating officer (COO) effective immediately. In this role, Motlagh will drive the Company’s overall business and R&D strategy while leading operational execution for both domestic and international markets. Reporting directly to chief executive officer, Tomoyuki Hasegawa, s...

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference taking place in Toronto on May 5 and 6. Satellos Co-founder and CEO Frank Gleeson will provide a presentation on May 5 and along with members of the management team, will participate in one-on-one m...

NEW YORK--(BUSINESS WIRE)--AV Laboratories (AVL), a clinical skin longevity brand that represents the apex in science-backed age-defying skin care, today announced the launch of Face Mist, the newest innovation in its portfolio. Designed to deliver instant and long-term hydration, the ultra-fine mist refreshes, replenishes, and fortifies the skin barrier whenever and wherever your skin needs it. Joining AVL’s lineup of scientifically advanced formulas, Face Mist ($88) complements the brand’s si...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, is pleased to announce the appointment of Dr. Pinchas Cohen to its Scientific Advisory Board (SAB). Dr. Cohen is an internationally recognized leading expert in healthy aging and mitochondrial biology. He serves as Dean of the University of Southern California (USC) Leonard Davis School of...